Page last updated: 2024-11-01

ondansetron and Anemia, Aplastic

ondansetron has been researched along with Anemia, Aplastic in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.

Research Excerpts

ExcerptRelevanceReference
"Severe aplastic anemia is a life-threatening bone marrow failure disorder."2.70Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. ( Brodsky, I; Brodsky, RA; Dorr, D; Jones, RJ; Karp, JE; Lee, SM; Seaman, PJ; Sensenbrenner, LL; Smith, BD, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, RA1
Sensenbrenner, LL1
Smith, BD1
Dorr, D1
Seaman, PJ1
Lee, SM1
Karp, JE1
Brodsky, I1
Jones, RJ1

Trials

1 trial available for ondansetron and Anemia, Aplastic

ArticleYear
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
    Annals of internal medicine, 2001, Oct-02, Volume: 135, Issue:7

    Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antiemetics; Cyclophosphamide; Dru

2001